How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods

November 4, 2021

Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addressed before a therapeutic vector reaches clinical application. With biophysical characterization tools, it is possible to address these questions and determine the best formulation for your AAV development needs. The proper tool will give you the high-quality data you require, without using lots of precious sample. Watch this video to learn how NanoTemper is addressing the needs of gene therapy researchers.

Previous
Use of self-interaction parameters derived from light scattering experiments for better developability assessment of biologic therapeutics
Use of self-interaction parameters derived from light scattering experiments for better developability assessment of biologic therapeutics

Up next
How do you get reproducible data from protein characterization experiments? Try following this DIN SPEC
How do you get reproducible data from protein characterization experiments? Try following this DIN SPEC

Reproducibility is a key tenet of scientific research, but many pharma groups have projects that collaborat...

Ready to tackle your challenging stability characterizations?

Discover tools